The 2025 revision of ISO 10993-1 introduces a more rigorous, evidence-driven system for biological evaluation, placing greater emphasis on chemical characterisation, toxicological justification and the alignment of risk assessment activities with MDR Annex I GSPRs. Manufacturers should expect a shift away from strictly test-focused strategies toward integrated, lifecycle-based biological safety assessments.